Form 4 Tracker
Latha Vairavan

SVP Chief Financial Officer · 3 filings · Latest: May 11, 2026

Arcutis Biotherapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ARQT
Latha VairavanSVP Chief Financial OfficerMay 11, 2026
Sale
$21.05435$9.2K85,978
ARQT
Latha VairavanSVP Chief Financial OfficerMay 4, 2026
Sale
$23.611,341$31.7K86,413
ARQT
Latha VairavanSVP Chief Financial OfficerMar 2, 2026
Sale
$25.182,853$71.8K87,754